Literature DB >> 8722685

Immunological abnormalities in myelodysplastic syndromes.

T J Hamblin1.   

Abstract

Entities:  

Mesh：

Year:  1996        PMID： 8722685

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  17 in total

1.  An unusual cutaneous manifestation of myelodysplastic syndrome: "pseudo-Koebner phenomenon".

Authors:  R DasGupta; S A Fairham; C Womack; C Burton; M Sivakumaran
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

2.  Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population.

Authors:  Dragomir Marisavljević; Nada Kraguljac; Zoran Rolović
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Sacroiliitis as an initial manifestation of acute myelogenous leukemia.

Authors:  Takumi Hoshino; Takafumi Matsushima; Yasuyuki Saitoh; Arito Yamane; Makiko Takizawa; Hiroyuki Irisawa; Takayuki Saitoh; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2006-12       Impact factor: 2.490

4.  Myelodysplastic syndrome associated with multiple autoimmune disorders.

Authors:  Dimitrios Farmakis; Evaggelos Polymeropoulos; Aikaterini Polonifi; Spyros Deftereos; Xanthoula Giakoumi; Harris Floudas; Antonia Grapsa; Athanasios Aessopos
Journal:  Clin Rheumatol       Date:  2005-04-13       Impact factor: 2.980

5.  Myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of Vater.

Authors:  T Takahashi; Y Kazama; H Shimizu; M Yoshimoto; M Tsujisaki; S Aoki; K Imai
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

6.  Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.

Authors:  S Giannouli; D Tzoanopoulos; K Ritis; G Kartalis; H M Moutsopoulos; M Voulgarelis
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

7.  Distinct roles of helper T-cell subsets in a systemic autoimmune disease.

Authors:  Katrina K Hoyer; Wilson F Kuswanto; Eugenio Gallo; Abul K Abbas
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

8.  Immunosuppressive therapy for myelodysplastic syndrome: efficacy of methylprednisolone pulse therapy with or without cyclosporin A.

Authors:  Toshiki Yamada; Hisashi Tsurumi; Senji Kasahara; Takeshi Hara; Michio Sawada; Hisataka Moriwaki
Journal:  J Cancer Res Clin Oncol       Date:  2003-07-10       Impact factor: 4.553

9.  Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.

Authors:  Atsushi Isoda; Atsushi Sakurai; Yoshiyuki Ogawa; Yuri Miyazawa; Akio Saito; Morio Matsumoto; Morio Sawamura
Journal:  Int J Hematol       Date:  2009-07-09       Impact factor: 2.490

10.  Hemophagocytic syndrome in elderly patients with underlying autoimmune diseases.

Authors:  Rie Tabata; Chiharu Tabata; Makoto Terada; Tomoko Nagai
Journal:  Clin Rheumatol       Date:  2009-01-23       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.